Assembly Bill A1675

2023-2024 Legislative Session

Relates to establishing an office of antibiotic resistance control and to establishing the antibiotics education fund

download bill text pdf

Sponsored By

Current Bill Status - In Assembly Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

co-Sponsors

2023-A1675 (ACTIVE) - Details

See Senate Version of this Bill:
S4021
Current Committee:
Assembly Health
Law Section:
Public Health Law
Laws Affected:
Add Art 2 Title 9 §§269-a - 269-n, Pub Health L; add §97-aaaa, St Fin L; amd §218-b, Lab L
Versions Introduced in 2021-2022 Legislative Session:
A10097, S8847

2023-A1675 (ACTIVE) - Summary

Relates to establishing an office of antibiotic-resistance control; establishes the antibiotics education fund; includes methicillin-resistant staphylococcus aureus (MRSA) and other antibiotic-resistant infections in the definition of airborne infectious disease.

2023-A1675 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   1675
 
                        2023-2024 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             January 17, 2023
                                ___________
 
 Introduced  by M. of A. L. ROSENTHAL, SIMON -- read once and referred to
   the Committee on Health
 
 AN ACT to amend the public health law, in relation  to  establishing  an
   office  of  antibiotic-resistance  control; to amend the state finance
   law, in relation to establishing the antibiotics education  fund;  and
   to amend the labor law, in relation to including methicillin-resistant
   staphylococcus aureus (MRSA) and other antibiotic-resistant infections
   in the definition of airborne infectious disease
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Legislative findings. Antibiotics are rightfully considered
 one of the medical miracles of the last century because of their  power-
 ful  ability  to  fight  illness and disease caused by bacteria. But the
 effectiveness of medically important antibiotics is now  at  great  risk
 due  to  their  misuse  and  overuse  in  medicine and agriculture. Many
 strains of bacteria have  evolved  resistance  to  antibiotics,  meaning
 instead  of  being  killed  by  the  drugs,  they survive, multiply, and
 spread. In fact, the more antibiotics are used, the  faster  antibiotic-
 resistant  bacteria  (aka  "superbugs")  emerge,  increasing the risk of
 contracting an antibiotic-resistant infection. If effective policy meas-
 ures are not soon adopted, some experts predict that by 2050,  antibiot-
 ic-resistant  infections will be responsible for more annual deaths than
 cancer.
   In recognition of the serious public health threat posed by  antibiot-
 ic-resistant  infections,  the  United  Nations General Assembly in 2016
 committed to taking action. The World Health Organization (WHO)  consid-
 ers it to be one of the biggest threats to global health, food security,
 and  international  development  today.  The  United  States Centers for
 Disease Control and Prevention  (CDC)  has  stated  that  fighting  this
 threat is a public health priority and estimates that each year, antibi-
 otic-resistant  bacteria  are  responsible  for  at  least  2.8  million
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD05817-01-3
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.